Document Detail

The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling.
MedLine Citation:
PMID:  21042766     Owner:  NLM     Status:  In-Process    
In a recent clinical observation, the growth of endothelial tumors, such as nasopharyngeal carcinoma, was repressed by the non-selective-adrenergic antagonist propranolol. In this study, we evaluated whether β-adrenoceptors (β-ARs), nuclear factor κB (NF-κB), vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) were involved in modulating cell apoptosis and cell cycle arrest by propranolol in human gastric adenocarcinoma cell lines (SGC-7901 and BGC-823) in vitro. Our results showed that the propranolol treatment inhibited cell proliferation in a concentration-dependent manner, suggesting the involvement of β-ARs in this cellular response. Propranolol-induced growth inhibition was associated with G0/G1 arrest and G2/M arrest depending upon the concentration. In addition, propranolol also induced apoptosis in both cell lines, as determined by Annexin V staining assay. Furthermore, propranolol decreased the level of NF-κB and then downregulated VEGF, Cox-2, MMP-2 and MMP-9 expression. Collectively, these results suggested that propranolol repressed gastric cancer cell growth through the inhibition of β-ARs and the downstream NF-κB-VEGF/MMP-2/9/COX-2 pathway.
Xinhua Liao; Xiangming Che; Wei Zhao; Danjie Zhang; Tieqiang Bi; Guanghui Wang
Related Documents :
11521756 - Bullatacin, a potent antitumor annonaceous acetogenin, inhibits proliferation of human ...
21451576 - The hyperactive sleeping beauty transposase sb100x improves the genetic modification of...
10483366 - The mode of cell death induced by photodynamic treatment depends on cell density.
21416346 - Electroporation technique of dna transfection.
12896906 - Cell cycle activation in lung adenocarcinoma cells by the erbb3/phosphatidylinositol 3-...
24649966 - Unicentric mixed variant castleman disease associated with intrabronchial plasmacytoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Oncology reports     Volume:  24     ISSN:  1791-2431     ISO Abbreviation:  Oncol. Rep.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9422756     Medline TA:  Oncol Rep     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1669-76     Citation Subset:  IM    
Department of General Surgery, First Affiliated Hospital of Medical College of Xi'an JiaoTong University, Xi'an 710061, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management.
Next Document:  Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma ...